GUDCA treatment partially attenuated down-regulation in SERCA2 induced by HFD, mitigating Ca2+ depletion from the ER lumen and inhibition of ER stress, then alleviating metabolic diseases, which may be the mechanism throughout the present study. Here, ATP2A2 is linked to metabolic disease.